Characterization of SLC22A18 as a tumor suppressor and novel biomarker in colorectal cancer

SLC22A18, solute carrier family 22, member 18, has been proposed to function as a tumor suppressor based on its chromosomal location at 11p15.5, mutations and aberrant splicing in several types of cancer and down-regulation in glioblastoma. In this study, we sought to demonstrate the significance of...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Yeonjoo, Jun, Yukyung, Lee, Hee-Young, Kim, Suyeon, Jung, Yeonhwa, Keum, Juhee, Lee, Yeo Song, Cho, Yong Beom, Lee, Sanghyuk, Kim, Jaesang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694837/
https://www.ncbi.nlm.nih.gov/pubmed/26196590

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694837/
https://www.ncbi.nlm.nih.gov/pubmed/26196590

Ejemplares similares